SpyBiotech Announces MHRA Clinical Trial Application Filing for SPYVLP01
— SpyBiotech’s lead program to target HCMV — Oxford, UK and Cambridge, MA (September 20, 2023) — SpyBiotech, a biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, announced that the company has filed a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory […]
SpyBiotech Announces MHRA Clinical Trial Application Filing for SPYVLP01 Read More »